吲哚菁绿引导结直肠癌淋巴结示踪的技术差异与结局
本文为叙述性综述,检索PubMed/MEDLINE至2026年7月,评估吲哚菁绿荧光成像在结直肠癌淋巴示踪和淋巴结识别中的应用。荧光成像可能改善淋巴引流可视化和淋巴结清扫,但方法学异质性大,对淋巴结转移诊断准确性尚无定论,长期生存数据有限。
要点
- 吲哚菁绿荧光成像可提高淋巴结检出数,偶可改变切除策略。
- 汇总淋巴结检出率91%和86.8%,直肠癌低于结肠癌。
- 汇总灵敏度63%–71%,假阴性率29%–37%,诊断准确性有限。
核心结论
- 吲哚菁绿荧光成像可能是术中淋巴示踪和增强淋巴结清扫的有价值工具。
- 方法学异质性大,无法对其诊断淋巴结转移状态的准确性做出确定结论。
- 需要标准化方案和高水平前瞻性研究来明确其最佳角色和长期肿瘤学影响。
研究设计与样本
- 叙述性综述,检索PubMed/MEDLINE至2026年7月,纳入评估吲哚菁绿荧光成像用于结直肠癌淋巴示踪和淋巴结识别的研究。
- 对 findings 进行叙述性总结。
主要发现
- 吲哚菁绿荧光成像可能改善淋巴引流可视化并支持更完整的淋巴结清扫。
- Meta分析报告汇总淋巴结检出率为91%和86.8%,因肿瘤位置、疾病分期和示踪技术而异,直肠癌检出率一般低于结肠癌。
- 报告汇总灵敏度分别为63%、64.3%和71%,对应假阴性率分别为37%、35.7%和29%。
- 吲哚菁绿荧光成像与淋巴结检出数增加相关,偶可改变切除策略,但长期生存数据有限且不一致。
- 吲哚菁绿剂量和浓度、注射途径和时机、成像平台及结局定义的异质性限制了研究间比较。
关键数值与推荐
- 汇总淋巴结检出率:91%和86.8%(Meta分析报告)。
- 汇总灵敏度:63%、64.3%和71%;对应假阴性率:37%、35.7%和29%。
- 直肠癌淋巴结检出率一般低于结肠癌。
临床怎么用
- 可考虑将吲哚菁绿荧光成像用于术中淋巴示踪以辅助淋巴结清扫。
- 应认识到其诊断淋巴结转移的假阴性率较高,不能替代病理分期。
- 需注意剂量、注射途径和时机等方案差异对结果的影响。
局限性
- 叙述性综述,非系统评价。
- 吲哚菁绿剂量和浓度、注射途径和时机、成像平台及结局定义存在显著异质性。
- 长期生存数据有限且不一致。
- 方法学异质性妨碍对其诊断准确性做出确定结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Indocyanine green is a fluorescent dye used in a wide range of specialties, including colorectal surgery. Although indocyanine green fluorescence imaging has been well established for assessing colorectal anastomotic perfusion, its role in lymph node mapping in colorectal cancer remains unclear. This narrative review aimed to provide an overview of the mechanism of action of indocyanine green-fluorescence imaging and its role in lymph node mapping in colorectal cancer. METHODS: PubMed/MEDLINE was searched through July 2026 for studies evaluating the use of indocyanine green-fluorescence imaging for lymphatic mapping and lymph node identification in colorectal cancer. Findings were narratively summarized. RESULTS: Indocyanine green-fluorescence imaging may improve visualization of lymphatic drainage and support a more complete lymphadenectomy. Meta-analyses have reported pooled lymph node detection rates of 91% and 86.8%, with substantial variation by tumor location, disease stage, and mapping technique, with generally lower detection rates in rectal than in colon cancer. Pooled sensitivities of 63%, 64.3%, and 71% were reported, corresponding to false-negative rates of 37%, 35.7%, and 29%, respectively. Although indocyanine green-fluorescence imaging was associated with an increased lymph node harvest and occasionally modified resection strategy, data on long-term survival remain limited and inconsistent. Heterogeneity in indocyanine green dose and concentration, injection route and timing, imaging platforms, and outcome definitions limits comparison across studies. CONCLUSION: Indocyanine green-fluorescence imaging might be a valuable tool for intraoperative lymphatic mapping and enhancing lymphadenectomy; however, substantial methodologic heterogeneity precludes definitive conclusions regarding its diagnostic accuracy for nodal metastatic status. Standardized protocols and high-quality prospective studies are needed to define its optimal role and long-term oncologic impact.
引用
- Saeidishahri S, Wagner L, Emile SH, et al. Navigating technical variations and outcomes in indocyanine green-guided lymph node mapping for colorectal cancer. Surgery. 2026. PMID: 42875265. doi:10.1016/j.surg.2026.110576
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。